Shorter radiation after breast surgery for certain node-positive cancer
Part of Cancer, Skin clinical trials.
This trial compares a shorter, more concentrated radiation schedule versus a standard shorter schedule after breast-conserving surgery. It looks at whether the treatment works well and is safe, especially for women whose lymph nodes also need radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a woman age 18 or older and able to sign consent
- You had breast-conserving surgery (not a full mastectomy) and still need radiation
- Your cancer is an invasive adenocarcinoma, and not the classic type of invasive lobular cancer
- Your lymph nodes are involved (node-positive), with no distant spread to other organs
- You cannot have had prior breast or chest (mediastinal) radiation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests shorter radiation schedules for people with breast cancer that has spread to lymph nodes or is high-risk. It aims to find a shorter course of radiation that is just as effective after surgery.
This trial compares two different schedules of radiation therapy after breast cancer surgery to see if a shorter course is as effective. It may help reduce the number of hospital visits for patients who have had breast-conserving surgery or a mastectomy.
This Phase 2 trial tests a shorter, focused radiation treatment after breast surgery, either alone or with an extra targeted boost. It’s for people with low-risk breast cancer and no spread to distant organs, aiming to keep results while reducing treatment time and side effects.
This study tests giving a shorter course of radiation to the whole breast after chemotherapy for early breast cancer. It aims to make treatment more convenient and may be an option for people who have had breast-conserving surgery.
This study compares two radiation schedules for breast cancer patients at high risk of cancer returning in lymph nodes. Both use modern radiation therapy, but one delivers treatment faster (ultra-hypofractionated) while the other uses a more moderate schedule. The goal is to see which approach works better with fewer side effects.
This trial tests a shorter course of radiation therapy (called extreme hypofractionation) after surgery for early-stage breast cancer. It aims to see if fewer, higher-dose radiation sessions are as effective and safe as standard radiation, potentially reducing treatment time.
Hear when a new Malignant Breast Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.